Dr. Richard Eugene Ramsay, MD

Dr. Ramsay practices at Orthopedic Surgery Sosp Jh07 - Nomc Orthopedics - HOPD in New Orleans, Louisiana.

Dr. Ramsay's NPI, 1790740694, was assigned on April 20, 2006. Dr. Ramsay graduated from University of Florida College of Medicine in 1969. Dr. Ramsay holds Alabama license MD.48552.

Dr. Ramsay's primary practice is Orthopedic Surgery Sosp Jh07 - Nomc Orthopedics - HOPD, at 1514 Jefferson Highway, New Orleans, LA 70121.

Dr. Ramsay's primary practice is Orthopedic Surgery Sosp Jh07 - Nomc Orthopedics - HOPD in New Orleans, Louisiana. Dr. Ramsay is also affiliated with USA Health University Hospital. The medical group on file is USA Health Physician Billing. Dmand AI also links Dr. Ramsay to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ramsay practices, 4 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Ramsay's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dmand AI has Dr. Ramsay's licenses on file in 6 states: Alabama, Florida, Georgia, Louisiana, Mississippi and Texas.

CMS data shows 82 Medicare services from Dr. Ramsay across 4 procedure codes in 2024, for 72 Medicare patients. Medicare paid $8,111 for them.

CMS counts 72 Medicare patients who saw Dr. Ramsay in 2024. The largest group is 65 to 74, with 30 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ramsay's median patient age at 40, with 64% women.

In 2024, Dr. Ramsay wrote 86 Medicare Part D claims for 18 patients. 34% of them were for generic drugs. CMS names the drug for 44 of them, across 1 drug with 11 or more claims each, at $56,270 in total drug cost. In 2023, CMS named 23 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Ramsay for performance year 2024, reported as part of a group. Dr. Ramsay accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Ramsay, published from 2012 to 2022. The most frequent topics are Anticonvulsants, Epilepsy and Administration, Oral. Dr. Ramsay has published most often in Epilepsia. Dr. Ramsay's most frequent co-authors are Page B. Pennell, MD, Aatif M. Husain, MD and Trudy D. Pang, MD.

CMS Open Payments shows 1,132 general payments to Dr. Ramsay from 51 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 59% of the total. Sunovion Pharmaceuticals Inc. paid the most, $192,516.

Dr. Ramsay graduated from University of Florida College of Medicine in 1969.